Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 2c

May 10, 2021 5:31 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.11, $0.02 better than the analyst estimate of $0.09. Revenue for the quarter came in at $30.2 million versus the consensus estimate of $32.1 million.

For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities